Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × Mercaptopurine × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Ovarian Neoplasms 1 Breast Neoplasms 1

Interventions

pembrolizumab 38 Cyclophosphamide 21 Paclitaxel 18 Carboplatin 18 olaparib 16 fludarabine 13 Nivolumab 13 Fulvestrant 11 Docetaxel 11 Gemcitabine 10 Bevacizumab 9 durvalumab 8 aldesleukin 8 veliparib 7 sargramostim 7 palbociclib 7 liposomal doxorubicin 7 Trastuzumab 7 Magnetic Resonance Spectroscopy 7 niraparib 6 atezolizumab 6 Surveys and Questionnaires 6 Ipilimumab 6 Cisplatin 6 avelumab 5 Specimen Handling 5 Interleukin-2 5 Fluorouracil 5 Capecitabine 5 Blood Specimen Collection 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01432145 2019-07-09

6MP

University of Oxford

Phase 2 Completed

74 enrolled 13 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡